Vaccination with mRNA vaccines against coronavirus disease 2019 (COVID-19) has been
associated with a risk of developing myocarditis and pericarditis, with an estimated …

Background The worldwide spread of coronavirus disease 2019 (COVID-19) is still not
under control and vaccination in Japan started in February 2021, albeit later than in Europe …

Acute myocarditis following mRNA COVID‐19 vaccination was reported by the European
Medicine Agency safety committee as a rare adverse event. We present a case series of …

Background: Several cases of myocarditis associated with COVID-19 mRNA vaccines have
recently been reported in which the mechanism of vaccine-induced myocarditis has not …

Introduction Reports of SARS-CoV-2 coronavirus (COVID-19) vaccine-related myocarditis,
particularly after mRNA vaccines, have raised concerns amongst the general public. This …

A new trend of myocarditis among young adults who received mRNA vaccines for COVID-19
is emerging. We present the case of a young adult who presented with chest pain 3 days …

Background and aims Recent media reports of myocarditis after receiving COVID-19
vaccines, particularly the messenger RNA (mRNA) vaccines, are causing public concern …

Since the beginning of the COVID-19 (Coronavirus Disease of 2019) pandemic, myocarditis
has received much attention and controversy as one of the more worrisome cardiovascular …

Vaccines against coronavirus 2019 disease (COVID-19) have shown to be greatly effective
in preventing viral spread, serious illness and death from this infectious disease and are …

After the surging rise in the Coronavirus disease 2019 (COVID-19) pandemic, the Food and
Drug Administration (FDA) approved emergency approval of vaccinations to prevent life …